Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Meera Sikka"'
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 10, Pp 4347-4353 (2024)
Background Defects in the production or action of erythropoietin (EPO) are important contributing factors in anemia. However, the exact impact of aging on levels of EPO and its role in the development of geriatric anemia is still underexplored. Moreo
Externí odkaz:
https://doaj.org/article/304fa3e12f584f0cb77b35361da1722f
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 12, Iss 8, Pp 1663-1668 (2023)
Background: Inflammation has several effects in the geriatrics with reference to iron deficiency anemia (IDA), anemia of chronic disease (ACD), and unexplained anemia (UA). Whether hyperinflammation is part of their pathogenesis or just incidental is
Externí odkaz:
https://doaj.org/article/20752fe89f794df0a102c17a05635b75
Publikováno v:
Journal of Laboratory Physicians, Vol 10, Iss 04, Pp 410-413 (2018)
INTRODUCTION: Aberrant expression of immunophenotypic markers is commonly found in patients of acute leukemia. T-ALL also shows aberrant markers such as CD13, CD33, CD117, CD10, and CD79a. Morphologically, T-ALL has been categorized into L1, L2, and
Externí odkaz:
https://doaj.org/article/48ecba2886274741a30dcca0259b1dec
Autor:
Sutapa B Neogi, ProfMD, Niveditha Devasenapathy, MBBS, Ranjana Singh, PhD, Himanshu Bhushan, MD, Duru Shah, MD, Hema Divakar, MD, Sanjay Zodpey, ProfMD, Sunita Malik, ProfMD, Smiti Nanda, ProfMD, Pratima Mittal, ProfMD, Achla Batra, ProfMD, Meenakshi B Chauhan, ProfMD, Sunita Yadav, MD, Harsha Dongre, ProfMD, Sumita Saluja, ProfMD, Vani Malhotra, ProfMD, Anjali Gupta, ProfMD, Roopa Sangwan, ProfMD, A G Radhika, DNB, Alpana Singh, MD, Sruti Bhaskaran, MD, Mrinalini Kotru, ProfMD, Meera Sikka, ProfMD, Sonika Agarwal, MD, Paul Francis, MD, Kasonde Mwingak, MMED, Dinesh Baswal, MD
Publikováno v:
The Lancet Global Health, Vol 7, Iss 12, Pp e1706-e1716 (2019)
Summary: Background: Intravenous iron sucrose is a promising therapy for increasing haemoglobin concentration; however, its effect on clinical outcomes in pregnancy is not yet established. We aimed to assess the safety and clinical effectiveness of i
Externí odkaz:
https://doaj.org/article/66c6ed91b7c34ae0abea7a1b437c4b89
Publikováno v:
Iranian Journal of Pathology, Vol 13, Iss 2, Pp 272-275 (2018)
Background & Objectives: In sepsis, enhanced fibrin formation, impaired fibrin degradation, and intravascular fibrin deposition lead to a prothrombotic state. The current study aimed at measuring various coagulation parameters to predict an early mar
Externí odkaz:
https://doaj.org/article/760c3df38a1b4be5af2774c0d289b872
Publikováno v:
Iraqi Journal of Hematology, Vol 7, Iss 1, Pp 26-32 (2018)
Background: Bone marrow examination is crucial diagnostic modality for evaluation of various hematological and nonhematological disorders. However, marrow aspirate smears and biopsy sections, even though performed simultaneously, are often assessed a
Externí odkaz:
https://doaj.org/article/8dd427a1a13c4af0a85d3afe469c8602
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 29, Iss 5, Pp 1035-1041 (2018)
Anemia is a common complication of chronic kidney disease (CKD) which is treated by erythropoiesis-stimulating agents. However, most of the patients do not respond adequately due to the development of functional iron deficiency (FID). The study was c
Externí odkaz:
https://doaj.org/article/34289977c0404e6a88fa6f94b0fce75e
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 117-138 (2017)
Externí odkaz:
https://doaj.org/article/773b456ffeb146fa9224300fa51e89b2
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 4, Pp EC25-EC29 (2017)
Introduction: Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with referenc
Externí odkaz:
https://doaj.org/article/b6664e58cac040c6b528742f02c2611d
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 11, Pp ED19-ED20 (2016)
Congenital leukaemia is a very rare entity comprising 0.8% of all childhood leukaemias. Pseudo-Chediak-Higashi Anomaly (PCHA) in acute leukaemia is a rarely described entity. However, co-existence of congenital myeloid leukaemia with PCHA is a very
Externí odkaz:
https://doaj.org/article/7ba1c401d5b244629be267eba2d9fe7e